← Leaderboards
Kazuhiko Adachi
Children'S Hospital Of Philadelphia
$3,461,046
Attributed
$3,461,046
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $556.4K · FY2005–07$1M$750K$500K$250K$0
'05
'06
'07
Funding mix
By agency
NIH$3,461,046 · 4
By mechanism
R01$2,186,166 · 1
U54$1,103,130 · 2
P60$171,750 · 1
Top collaborators
No co-investigators on record.
Most similar at Children'S Hospital Of Philadelphia
Same institution · by research overlap
- Mitchell J Weiss$27,379,685
- Stuart A Weinzimer$11,256,359
- Toshio Asakura$2,380,360
- Alan R. Cohen$10,567,103
- Kwaku Ohene-Frempong$11,449,096
Others in their field
Top investigators on “Polymerization”
- Ernest Fontes · Cornell University$53,099,382
- David Rubin · Cornell University$39,936,738
- Joel D Brock · Cornell University$39,936,738
- Eric Baer · Case Western Reserve University$37,501,250
- Donald H Bilderback · Cornell University$31,898,792
- Marc A Hillmyer · University Of Minnesota-Twin Cities$24,454,086
Research focus
PolymerizationSickle Cell AnemiaHemoglobin SsSite Directed MutagenesisHemoglobin FThermodynamicsElectron MicroscopyIntermolecular InteractionProtein Protein InteractionCircular DichroismTransfection /Expression VectorInhibitor /AntagonistProtein StructureGene TherapyErythrocytesGenetic ManipulationRetroviridaeLow Angle X Ray Diffraction AnalysisConformationHemoglobin AsGenetically Modified AnimalsLaboratory MouseHydropathyHemoprotein Structure
Grant awards (15)
Structure-Based Antisickling Peptides that Inhibit Hb S Polymerization$249,668
U54 · FY2007 · HL · contact PI
Structure-Based Antisickling Peptides that Inhibit Hb S Polymerization$222,918
U54 · FY2006 · HL · contact PI
HBF Variants for Gene Therapy of Sickle Cell Disease$340,000
R01 · FY2005 · HL
Structure-Based Antisickling Peptides that Inhibit Hb S Polymerization$216,424
U54 · FY2005 · HL
HBF Variants for Gene Therapy of Sickle Cell Disease$340,000
R01 · FY2004 · HL
Structure-Based Antisickling Peptides that Inhibit Hb S Polymerization$210,120
U54 · FY2004 · HL
HBF Variants for Gene Therapy of Sickle Cell Disease$340,000
R01 · FY2003 · HL
Identification of Structure-Based Antisickling Peptides that Inhibit HBS Polymeri$204,000
U54 · FY2003 · HL
HBF Variants for Gene Therapy of Sickle Cell Disease$340,000
R01 · FY2002 · HL
STUDIES OF HEMOGLOBIN S USING A RECOMBINANT DNA STRATEGY$0
P60 · FY2002 · HL
STUDIES OF HEMOGLOBIN S USING A RECOMBINANT DNA STRATEGY$0
P60 · FY2002 · HL
HBF VARIANTS FOR GENE THERAPY OF SICKLE CELL DISEASE$419,188
R01 · FY2001 · HL
STUDIES OF HEMOGLOBIN S USING A RECOMBINANT DNA STRATEGY$0
P60 · FY2001 · HL
HBF VARIANTS FOR GENE THERAPY OF SICKLE CELL DISEASE$406,978
R01 · FY2000 · HL
STUDIES OF HEMOGLOBIN S USING A RECOMBINANT DNA STRATEGY$171,750
P60 · FY2000 · HL